Serum proteomics screening intercellular adhesion molecule-2 improves intermediate-risk stratification in acute myeloid leukemia
Background: The clinical risk classification of acute myelocytic leukemia (AML) is largely based on cytogenetic and molecular genetic detection. However, the optimal treatment for intermediate-risk AML patients remains uncertain. Further refinement and improvement of prognostic stratification are th...
Main Authors: | Nan Zhang, Xiaoyan Liu, Jinxian Wu, Xinqi Li, Qian Wang, Guopeng Chen, Linlu Ma, Sanyun Wu, Fuling Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-10-01
|
Series: | Therapeutic Advances in Hematology |
Online Access: | https://doi.org/10.1177/20406207221132346 |
Similar Items
-
Development of a risk assessment model for cardiac injury in patients newly diagnosed with acute myeloid leukemia based on a multicenter, real-world analysis in China
by: Linlu Ma, et al.
Published: (2024-01-01) -
Global burden of hematologic malignancies and evolution patterns over the past 30 years
by: Nan Zhang, et al.
Published: (2023-05-01) -
Intercellular Adhesion Molecule 1: More than a Leukocyte Adhesion Molecule
by: Cameron D. Haydinger, et al.
Published: (2023-05-01) -
Pan-cancer analysis revealing that PTPN2 is an indicator of risk stratification for acute myeloid leukemia
by: Xuanyu Wang, et al.
Published: (2023-10-01) -
Role of intercellular adhesion molecules in the development of the endometrial neoplasias
by: E E Shelokova, et al.
Published: (2011-09-01)